posted                      

Upon the recommendation of the FDA (Food and Drug Administration), all drugs containing phenylpronalamine should be withdrawn from the U.S. market. This decision was based on a study conducted to investigate the risk of hemorrhagic stroke associated with the use of phenylpronalamine. The study reported an association between phenylpronalamine use and hemorrhagic stroke in women. The increase risk of hemorrhagic stroke was for women using phenylpronalamine for weight control and as a nasal decongestant product. Although the study showed that the risk of hemorrhagic stoke is found mostly in women, men may also be at risk.
>
>
>
>The following is a list of all drugs containing phenylpronalamine that are still available and in use in the Egyptian market:
>
>1. Conta-Flu
>
>2. Antiflu
>
>3. Nova-C-M
>
>4. Coldact
>
>5. Flustop
>
>6. Flurest
>
>7. Rhinomol
>
>8. Pararhinol
>
>9. Michaelon
>
>10. Noflu
>
>11. Coricidin D
>
>12. Rhinogesic
>
>13. Contact 12
>
>14. Eskornade
>
>15. Night and Day
>
>16. Vegaskine Aduls Syrup
>
>17. Sinutab
>
>18. Rhinopront Syrup
>
>19. Denoral
>
>20. Coflin
>
>Please, avoid using the above drugs even if prescribed by your treating physician.
>
>

Posts: 516 | Registered: Jul 2005  |  IP: Logged | 

posted                      

I posted this message before on Visiting Egypt. I checked it out on the FDA webiste and it is a genuine warning, thanks for bringing it up again.

Posts: 4576 | From: Cairo | Registered: Jun 2002  |  IP: Logged |